Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 399, doi. 10.1007/s00198-022-06630-5
- By:
- Publication type:
- Article
Works matching IS 0937-941X AND VI 34 AND IP 2 AND DT 2023
Results: 25
1
2
Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 387, doi. 10.1007/s00198-022-06616-3
- By:
- Publication type:
- Article
3
Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 405, doi. 10.1007/s00198-022-06609-2
- By:
- Publication type:
- Article
4
Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up.
- Published in:
- 2023
- By:
- Publication type:
- Letter
5
Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 357, doi. 10.1007/s00198-022-06623-4
- By:
- Publication type:
- Article
6
Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 379, doi. 10.1007/s00198-022-06622-5
- By:
- Publication type:
- Article
7
Response letter to "sarcopenia, osteoporosis and fractures: what we see".
- Published in:
- 2023
- By:
- Publication type:
- Letter
8
Response to: Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated.
- Published in:
- 2023
- By:
- Publication type:
- Letter
9
Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia.
- Published in:
- 2023
- By:
- Publication type:
- Letter
10
Appropriate dosing of burosumab in tumor-induced osteomalacia.
- Published in:
- 2023
- By:
- Publication type:
- Letter
11
Discontinuation of denosumab in men with prostate cancer.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 291, doi. 10.1007/s00198-022-06610-9
- By:
- Publication type:
- Article
12
Mortality following proximal humerus fracture—a nationwide register study of 147,692 fracture patients in Sweden.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 349, doi. 10.1007/s00198-022-06612-7
- By:
- Publication type:
- Article
13
Lipopolysaccharide-binding protein and bone health: data from a population-based sample of men.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 309, doi. 10.1007/s00198-022-06602-9
- By:
- Publication type:
- Article
14
Fracture liaison service model: project design and accreditation.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 339, doi. 10.1007/s00198-022-06600-x
- By:
- Publication type:
- Article
15
Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 319, doi. 10.1007/s00198-022-06575-9
- By:
- Publication type:
- Article
16
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 299, doi. 10.1007/s00198-022-06595-5
- By:
- Publication type:
- Article
17
Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 269, doi. 10.1007/s00198-022-06584-8
- By:
- Publication type:
- Article
18
Retrospective analyses of clinical features in 28 Chinese patients with type V osteogenesis imperfecta: new perspectives in an old issue.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 369, doi. 10.1007/s00198-022-06581-x
- By:
- Publication type:
- Article
19
Pharmacist interventions in osteoporosis management: a systematic review.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 239, doi. 10.1007/s00198-022-06561-1
- By:
- Publication type:
- Article
20
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 327, doi. 10.1007/s00198-022-06597-3
- By:
- Publication type:
- Article
21
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 255, doi. 10.1007/s00198-022-06543-3
- By:
- Publication type:
- Article
22
Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated.
- Published in:
- 2023
- By:
- Publication type:
- Letter
23
Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 2, p. 213, doi. 10.1007/s00198-022-06523-7
- By:
- Publication type:
- Article
24
Sarcopenia, osteoporosis, and fractures: what we see mainly depends on how we look?
- Published in:
- 2023
- By:
- Publication type:
- Letter
25
Comments on "Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor